POINT Biopharma Global Management
Management criteria checks 4/4
POINT Biopharma Global's CEO is Joe McCann, appointed in Jan 2020, has a tenure of 3.92 years. total yearly compensation is $2.84M, comprised of 16.9% salary and 83.1% bonuses, including company stock and options. directly owns 3.28% of the company’s shares, worth $43.70M. The average tenure of the management team and the board of directors is 2.5 years and 3 years respectively.
Key information
Joe McCann
Chief executive officer
US$2.8m
Total compensation
| CEO salary percentage | 16.9% |
| CEO tenure | 3.9yrs |
| CEO ownership | 3.3% |
| Management average tenure | 2.5yrs |
| Board average tenure | 3yrs |
Recent management updates
Recent updates
POINT Biopharma Global Inc. (NASDAQ:PNT) Analysts Just Slashed This Year's Estimates
Aug 20
We Think POINT Biopharma Global (NASDAQ:PNT) Can Easily Afford To Drive Business Growth
Feb 01A Look At The Fair Value Of POINT Biopharma Global Inc. (NASDAQ:PNT)
Oct 18Point Biopharma plummets on announcing common stock offering
Sep 13POINT Biopharma Global GAAP EPS of -$0.27 misses by $0.05
Aug 12CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | US$97m |
| Jun 30 2023 | n/a | n/a | US$97m |
| Mar 31 2023 | n/a | n/a | US$98m |
| Dec 31 2022 | US$3m | US$480k | US$98m |
| Sep 30 2022 | n/a | n/a | -US$79m |
| Jun 30 2022 | n/a | n/a | -US$72m |
| Mar 31 2022 | n/a | n/a | -US$56m |
| Dec 31 2021 | US$740k | US$392k | -US$46m |
| Sep 30 2021 | n/a | n/a | -US$37m |
| Jun 30 2021 | n/a | n/a | -US$23m |
| Mar 31 2021 | n/a | n/a | -US$18m |
| Dec 31 2020 | US$282k | US$218k | -US$13m |
Compensation vs Market: Joe's total compensation ($USD2.84M) is below average for companies of similar size in the US market ($USD5.06M).
Compensation vs Earnings: Joe's compensation has been consistent with company performance over the past year.
CEO
Joe McCann (45 yo)
3.9yrs
Tenure
US$2,839,772
Compensation
Dr. Joe McCann, Ph.D. is Chief Executive Officer at POINT Biopharma Global Inc. since January 2020 and has been its Director since September 2019. Dr. McCann has overall responsibility for the day-to-day o...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 4.3yrs | US$2.57m | 8.19% $ 109.1m | |
| CEO & Director | 3.9yrs | US$2.84m | 3.28% $ 43.7m | |
| Chief Medical Officer & Director | 3.9yrs | US$598.69k | 2.82% $ 37.6m | |
| Executive Vice President of Clinical Development | 3.3yrs | US$1.87m | 0% $ 0 | |
| CFO & Corporate Secretary | 3.3yrs | US$703.01k | no data | |
| Chief Operating Officer | 2yrs | no data | no data | |
| SVP of People & Culture | less than a year | no data | no data | |
| VP of Corporate Affairs & Chief of Staff | no data | no data | no data | |
| Executive Vice President of Regulatory Affairs | 2.5yrs | no data | no data | |
| Senior Vice President of Business Development | 1.9yrs | no data | no data | |
| Executive VP of Commercial | 1.5yrs | no data | no data | |
| Senior Vice President of Chemistry Manufacturing & Controls | less than a year | no data | no data |
2.5yrs
Average Tenure
52yo
Average Age
Experienced Management: PNT's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 4.3yrs | US$2.57m | 8.19% $ 109.1m | |
| CEO & Director | 4.3yrs | US$2.84m | 3.28% $ 43.7m | |
| Chief Medical Officer & Director | 4.3yrs | US$598.69k | 2.82% $ 37.6m | |
| Independent Director | 3.6yrs | US$176.85k | 0.037% $ 487.6k | |
| Independent Director | 2.5yrs | US$170.00k | 0.0016% $ 21.3k | |
| Independent Director | 3yrs | US$184.35k | 0.020% $ 269.9k | |
| Lead Independent Director | 3yrs | US$210.24k | 0.039% $ 523.4k | |
| Independent Director | 2.5yrs | US$170.00k | 0.0035% $ 46.2k | |
| Director | less than a year | no data | no data |
3.0yrs
Average Tenure
59yo
Average Age
Experienced Board: PNT's board of directors are considered experienced (3 years average tenure).